Document is current
Any future updates will be listed below
-
Authors
Ciccarone, Daniel https://orcid.org/0000-0002-2355-5477
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (DA054190)
- License Information
-
More Information
Article History
Received: 16 September 2025
Revised: 23 September 2025
Accepted: 6 October 2025
First Online: 10 November 2025
Declarations
: Dr. Daniel Ciccarone reports the following relevant financial relationships during the past 60 months: 1, he is a scientific advisor to Celero Systems and 2, he has been retained as an expert witness in ongoing prescription opioid litigation by Motley Rice, LLP.
: He reports the following non-financial competing interest: he is voluntary Medical Director for Remedy Alliance.
